Related by context. All words. (Click for frequent words.) 80 activated partial thromboplastin 69 serum cortisol 68 doxorubicin docetaxel 67 aspartate aminotransferase AST 67 tinzaparin 66 neurologic progression 66 IOP lowering 66 AST ALT 66 tipranavir r 66 alanine aminotransferase 66 serum urate 66 nicardipine 66 QTcF 66 8mg/kg 65 biochemical relapse 65 atorvastatin #mg 65 aspartate aminotransferase 65 ULORIC 65 mg kg dose 65 epoetin alpha 65 serum phosphorous 65 #mg/day [001] 65 #mg/day [002] 65 bolus dose 65 hMG 65 OGTT 65 rHuEPO 65 corrected QT interval 65 hematological parameters 65 fluticasone salmeterol 65 irbesartan 65 4mg/kg 65 urine albumin 65 vasopressor 65 clomipramine 65 intravenous bolus 65 mL/min/#.# m 2 64 abacavir lamivudine 64 lispro 64 relapsed MM 64 fructosamine 64 IV bolus 64 lumbar spine BMD 64 serum aminotransferase levels 64 lactate dehydrogenase 64 IFN beta 64 β blocker 64 platelet reactivity 64 serum phosphate 64 subcutaneous enoxaparin 64 alteplase 64 Cmax 64 Telintra 64 plasma renin activity 64 q#h 64 rtPA 64 antibody titer 64 paricalcitol 64 Solid Tumors criteria 64 dose dependently 64 SGPT 64 caspofungin 64 intima media thickness 63 isoproterenol 63 pyrazinamide 63 bolus injection 63 dalteparin 63 somatostatin analog 63 IELT 63 CIMZIA TM 63 urinary N telopeptide 63 tirofiban 63 oral rivaroxaban 63 HbA 1c levels 63 serum calcium levels 63 serum concentrations 63 calculated creatinine clearance 63 gastric pH 63 antiandrogen 63 PSADT 63 rFSH 63 corticosteroid dose 63 methacholine challenge 63 desvenlafaxine succinate 63 uM 63 virological response 63 glycated hemoglobin levels 63 GnRH agonist 63 cefotaxime 63 TNF antagonist 63 antithymocyte globulin 63 liver histology 63 #.#mg/dL 63 severe exacerbations 63 cTnI 63 morphometric vertebral fractures 63 symptomatic VTE 63 nadolol 63 ug kg 63 electrical cardioversion 63 timepoints 63 ZOLINZA 63 hemodynamic variables 63 mesilate 63 International Normalized Ratio 62 glomerular filtration 62 budesonide pMDI 62 hyperphenylalaninemia HPA due 62 fosamprenavir 62 lymphocyte counts 62 serum estradiol 62 daily subcutaneous injections 62 haematologic 62 glycosylated hemoglobin levels 62 anagrelide 62 mcg mL 62 atazanavir ritonavir 62 alanine aminotransferase ALT 62 Crohn Disease Activity 62 plasma glucose levels 62 ritonavir boosted 62 ropivacaine 62 clodronate 62 #mg BID [003] 62 HOMA IR 62 doxorubicin cyclophosphamide 62 potent CYP#A# inhibitors 62 vWF 62 progression TTP 62 radiotherapy RT 62 PEG IFN 62 mycophenolic acid 62 detectable HCV RNA 62 epoetin beta 62 β blockers 62 iPTH 62 chemoradiation therapy 62 metastatic malignant 62 APTIVUS r 62 serum TSH 62 #mg/m# [001] 62 lactate dehydrogenase LDH 62 intermittent dosing 62 ARB telmisartan 62 acromegalic patients 62 Flu Cy 62 #ng/ml 62 QD dosing 62 PRADAXA #mg 62 ALT AST 62 CANCIDAS 62 serum uric acid 62 lanthanum carbonate 62 interferon ribavirin 62 PSA nadir 62 elevated transaminases 62 methylprednisolone 62 #ß 62 gliclazide 62 zoledronate 62 serum ALT 62 salmeterol fluticasone 62 liver enzymes ALT 62 serum lipid 62 MULTAQ 62 SCr 62 detemir 62 mycophenolate mofetil MMF 62 adalimumab Humira 62 inotropic 62 intravesical therapy 62 Danazol 62 everolimus eluting stents 62 plasma cortisol 62 Serum creatinine 62 cardiac repolarization 62 â ‰ ¥ 62 Bosentan 62 #mg/m# [002] 62 unfractionated heparin UFH 62 neutrophil counts 62 HBeAg seroconversion 61 MGd 61 ribavirin USP 61 transaminase 61 xanthine oxidase inhibitor 61 achieved ACR# 61 serum creatinine levels 61 sitaxsentan 61 intravenous cyclophosphamide 61 myocardial reperfusion 61 rt PA 61 flutamide 61 TPV r 61 conventional DMARDs 61 BENICAR HCT 61 perioperatively 61 fluvastatin 61 coagulation parameters 61 fibrinolysis 61 overt nephropathy 61 glycosylated hemoglobin HbA1c 61 μg kg 61 CYP#D# inhibitor 61 posttreatment 61 zonisamide SR 61 elevated ALT 61 postoperative complication 61 serum phosphorus 61 intravenously administered 61 AZT zidovudine Retrovir 61 Montgomery Åsberg Depression 61 noninferior 61 NIHSS 61 triiodothyronine 61 hemoglobin Hb 61 ribavirin therapy 61 mg qd 61 Hypotension 61 aminotransferases 61 certolizumab 61 neostigmine 61 creatinine clearance 61 LPV r 61 #mg doses [002] 61 pharmacokinetic parameters 61 mg/m2 dose 61 AUC0 61 CsA 61 creatinine ratio 61 coadministration 61 CK MB 61 BENICAR 61 interferon alfa 2b 61 oral prednisone 61 idarubicin 61 CCyR 61 cyclophosphamide methotrexate 61 steroid dexamethasone 61 fasting plasma 61 pentoxifylline 61 thyroglobulin 61 sUA levels 61 crossclamp 61 atrial pacing 61 virologic failure 61 lenalidomide dexamethasone 61 hematologic toxicity 61 BRINAVESS 61 Known hypersensitivity 61 recurrent glioblastoma multiforme 61 BYSTOLIC 61 serum PSA 61 transdermal estradiol 61 5-FU/LV 61 biphasic insulin aspart 61 estramustine 61 min -1 61 intradermal injections 61 serum testosterone 61 nadroparin 61 FOLFOX6 61 opioid analgesia 61 insulin glulisine 61 sodium nitroprusside 61 oral anticoagulation 61 isoprostane 61 Secondary endpoints included 61 moderately emetogenic 61 oxycodone CR 61 μg liter 61 rFVIIa 61 periprocedural 61 receptor blocker 61 VELCADE melphalan 61 FDA defined valvulopathy 61 #mg dose [003] 61 GHRH 61 colorectal adenoma 61 severe neutropenia 61 HBeAg negative patients 61 cis retinoic acid 61 lanreotide 61 saline placebo 61 CI -#.# 61 Plasma concentrations 61 postintervention 61 inhaled iloprost 61 #ug [002] 61 μg ml 61 BARACLUDE ® 61 Vidaza azacitidine 61 bronchodilation 61 serum bicarbonate 61 primidone 61 hemoglobin A1c HbA1c 61 placebo p = 61 TURBT 61 serum phosphate levels 61 dose cohort 61 endometrial thickness 61 pamidronate 61 dose colchicine 61 DAS# CRP 61 pT3 61 QTc 60 postprocedure 60 intravenous dosing 60 mg/m2/day 60 EDARBI 60 pioglitazone HCl 60 plasma triglycerides 60 IV tPA 60 bronchoalveolar lavage 60 Kinoid 60 maximal dose 60 Secondary endpoints include 60 pCR 60 salivary cortisol 60 dehydroepiandrosterone sulfate 60 #.#/#.# mmHg [001] 60 #.#mg/kg [002] 60 serum IGF 60 polymyxin B 60 weekly subcutaneous injections 60 EXJADE 60 mucosal healing 60 serum potassium 60 fibrinolytic 60 μmol L 60 verteporfin 60 #.#/#.# mm Hg [003] 60 systemic hypotension 60 Tasigna prolongs 60 interquartile range 60 pg ml 60 euthyroid 60 vecuronium 60 atrioventricular block 60 asymptomatic carotid stenosis 60 creatinine levels 60 IL 1ß 60 postdose 60 mcg BID 60 baseline HbA1c 60 antigen PSA levels 60 ribavirin RBV 60 mg ustekinumab 60 pulmonary exacerbation 60 mmol kg 60 thrombocytopenic 60 aprepitant 60 mL kg 60 attain statistical significance 60 rosuvastatin #mg 60 transaminases 60 P = .# 60 peginterferon alfa 60 #mg QD [002] 60 dexamethasone Decadron 60 CYT# QbG# 60 ketorolac 60 vasoactive 60 systemic corticosteroids 60 baseline Hb 60 postprandial glycemia 60 autoantibody levels 60 SGOT 60 imatinib therapy 60 ACTEMRA TM 60 myelodysplastic myeloproliferative diseases 60 aminotransferase levels 60 Clinically significant 60 anti Xa 60 QTc intervals 60 corifollitropin alfa 60 insulin detemir 60 fasting plasma glucose FPG 60 preoperative PSA 60 remifentanil 60 piperacillin tazobactam 60 dosing cohort 60 5mg/kg 60 pmol L 60 administered subcutaneously 60 TLUS 60 Y BOCS 60 serum urate levels 60 azilsartan medoxomil 60 warfarin anticoagulation 60 PASI scores 60 moderate renal impairment 60 tumor necrosis 60 tranylcypromine 60 bioavailable testosterone 60 glomerular filtration rate 60 adriamycin 60 dihydrochloride 60 neointimal hyperplasia 60 symptomatic intracranial hemorrhage 60 CYP #D# 60 IFN α 60 dosage regimens 60 urate lowering therapy 60 injected subcutaneously 60 NMIBC 60 fosbretabulin 60 thromboxane A2 60 thyroid carcinoma 60 intracoronary 60 ADCS CGIC 60 apnea hypopnea 60 alefacept 60 dosing frequency 60 pg mL 60 macrolide antibiotic 60 intact parathyroid hormone 60 pharmacodynamic PD 60 leukocyte count 60 hemoglobin A1c levels 60 intratympanic 60 flecainide 60 undetectable HBV DNA 60 leukocyte counts 60 docetaxel chemotherapy 60 pegylated alpha interferon 60 EBRT 60 rabeprazole 60 HDRS 60 potentiation 60 colorectal cancer liver metastases 60 μg mL 60 GI motility 60 nanomolar range 60 monophasic 60 mild renal insufficiency 60 teriflunomide 60 EBMT criteria 60 iloprost 60 CrCl 60 EFFEXOR XR 60 sFlt 1 60 Natalizumab 60 artery stenosis 60 LEXIVA r 60 primary aldosteronism 60 adrenocorticotropic hormone 60 mmHg diastolic 60 cefazolin 60 docetaxel Taxotere ® 60 endoscopic remission 60 μg d 60 Subgroup analysis 60 nmol liter 60 cranial irradiation 60 pyridostigmine 60 hematologic parameters 60 response CCyR 60 plasma glucose 60 genotypic resistance 60 QTc interval 60 ATACAND 60 FOLPI 60 non splenectomized 60 hemodilution 60 undetectable viral 60 mCi 60 nucleoside analog 60 NMDA antagonist 60 dosing interval 59 olmesartan 59 divalproex sodium 59 FUSILEV enhances 59 mitoxantrone plus 59 plus prednisone prednisolone 59 trastuzumab Herceptin ® 59 mg TID 59 sulphonylureas 59 lumbar spine bone 59 GH secretion 59 mcg QD 59 REMINYL ® 59 serum sodium 59 prolonged QT interval 59 QTc prolongation 59 hours postdose 59 serum magnesium 59 ALGRX 59 ALT elevations 59 adenoma recurrence 59 sUA 59 epirubicin 59 nmol 59 palifermin 59 postoperative morbidity 59 tumor lysis syndrome 59 baseline LDH 59 dimeglumine 59 alfa 2a 59 intravenous tissue plasminogen 59 #OHD 59 parasitemia 59 p# activation 59 thyrotropin 59 eculizumab therapy 59 F FDG PET 59 HER2 expression 59 salivary flow 59 GSK# [001] 59 Helicobacter pylori eradication 59 SPRYCEL ® 59 Aptivus ® 59 ^ sup #m 59 plasma uric acid 59 QT QTc 59 TMC# r 59 Capecitabine 59 RAS blockers 59 mg QD 59 Non inferiority 59 specific antigen PSA 59 #mg doses [001] 59 serum LDL cholesterol 59 mmHg p = 59 clinicopathological features 59 FOLFOX4 59 Elitek 59 fasting triglycerides 59 CRp 59 GnRH antagonist 59 endogenous EPO 59 hypomagnesemia 59 nelfinavir 59 YMRS 59 peptide BNP 59 factor Xa 59 gonadotrophin releasing hormone GnRH 59 thyroid stimulating hormone 59 tryptase 59 alkylating agent 59 binary restenosis 59 dobutamine 59 partial remissions 59 recurrent venous thromboembolism 59 torsade de pointes 59 Visual Analogue Scale VAS 59 HBV DNA levels 59 ADAS cog 59 montelukast 59 radical prostatectomy RP 59 octreotide acetate 59 % Confidence Interval 59 serum HBV DNA 59 mesalazine 59 #mg/kg [002] 59 PaO 2 59 -#.# ± [002] 59 locomotor activity 59 LMWH 59 MAGE A3 ASCI 59 dose proportionality 59 SSRI SNRI 59 stimulated insulin secretion 59 HMG CoA reductase inhibitor 59 bisoprolol 59 oral antidiabetic medication 59 D dimer 59 micafungin 59 protease inhibitor PI 59 recurrent VTE 59 rocuronium 59 oxybutynin 59 isoenzyme 59 bovine thrombin 59 splenectomized patients 59 Akt activation 59 thrombocytopenic patients 59 beta blocker therapy 59 prednisone prednisolone 59 Doxil ® 59 pegylated interferon alfa 59 Decitabine 59 ritonavir boosted lopinavir 59 paraprotein 59 mcg kg 59 peak plasma concentrations 59 lymphocyte count 59 MADRS score 59 Tasimelteon 59 EGFR TKI 59 ml kg 59 Angiotensin Converting Enzyme 59 Infusion Reactions Severe 59 endothelial activation 59 plus methotrexate 59 DAPT 59 pegylated liposomal doxorubicin 59 bronchial hyperresponsiveness 59 selective modulator 59 aplindore 59 argatroban 59 ELOXATIN 59 umol L 59 Pegylated Liposomal Doxorubicin 59 #mg dose [001] 59 LNG IUS 59 folinic acid 59 serum prostate 59 aspirin clopidogrel 59 lopinavir r 59 HSCT 59 #mg dose [002] 59 Eligen R B# 59 Dasatinib 59 mediated inhibition 59 Tarceva TM 59 fibrinolytic therapy 59 flow mediated dilation 59 Retreatment 59 ADAS Cog 59 Postoperatively 59 ACTH 59 subcutaneous insulin 59 tacrolimus ointment 59 hsCRP levels 59 Folfox 59 tolterodine 59 Postoperative complications 59 MAS XR 59 FAMPYRA 59 highly emetogenic 59 Posaconazole 59 LVSD 59 receiving VICTRELIS 59 MMSE score 59 pulmonary arterial 59 bortezomib refractory 59 mineral density BMD 59 Ventavis ® 59 nephrotoxicity 59 aminophylline 59 #.#mmol L [002] 59 blood glucose concentrations 59 urocortin 2 59 PCWP 59 Pegasys ® 59 busulfan 59 NIH CPSI 59 glycoprotein IIb IIIa inhibitors 59 transaminase elevations 59 albumin excretion 59 inhaled budesonide 59 peg interferon 59 creatine kinase 59 recombinant tissue plasminogen 59 eplerenone 59 DLTs 59 #mmHg [001] 59 sorafenib Nexavar 59 achieved statistical significance 59 PegIFN RBV 59 liver resection 59 Primary endpoints 59 subcutaneously injected 59 mecamylamine 59 QRS duration 59 Intravitreal 59 PEGylated anti 59 creatine kinase MB 59 clopidogrel Plavix 59 diabetic gastroparesis 59 Xelox 59 antiangiogenic therapy 59 AGILECT R 59 nitroprusside 59 RLAI 59 kg -1 59 Androxal TM 59 terfenadine 59 Viral load 59 #.#mmHg 59 achieved CCyR 59 LHRH agonists 59 TNF α 59 CIMZIA TM certolizumab pegol 59 RoACTEMRA 59 Ejection Fraction 59 multivariable analysis 59 radiosensitivity 59 clotrimazole 59 Index CDAI 59 REYATAZ r arm 59 PROMACTA 59 coronary stenosis 59 systemic corticosteroid 59 mg kg hr 59 mg m² 59 Azacitidine 59 IIIa inhibitors 59 receptor blockers 59 plasma HCV RNA 59 LPS induced 59 ertapenem 59 subcutaneous immunoglobulin 59 elevated LDH 59 octreotide 59 microgram kg 59 -#.# log# copies mL 59 maximally tolerated dose 59 6mg 59 streptokinase 58 NPH insulin 58 CDK inhibitor 58 assessing T DM1 58 tapentadol ER 58 lopinavir r arm 58 hsCRP 58 crizotinib PF # 58 IIIa inhibitor 58 levodopa induced dyskinesia 58 intramuscularly 58 mCi kg 58 TO AVOID PREGNANCY WHILE 58 antidiabetic medications 58 KAPIDEX 58 topically administered 58 posttransplant 58 reinfarction 58 neoadjuvant 58 prazosin 58 #.#g/day 58 sub maximal 58 deep venous thromboses 58 KRAS mutations occur 58 GOUT 58 detrusor 58 nab paclitaxel 58 microsomal 58 racemic albuterol 58 log# copies mL 58 Pharmacodynamic 58 tracheal intubation 58 mycophenolate mofetil 58 Secondary endpoints 58 Pharmacokinetics PK 58 pulmonary artery pressure 58 induce orthostatic hypotension 58 guanfacine extended release 58 endothelin receptor antagonists 58 adjunctive placebo 58 fulvestrant 58 mg tid 58 pT2 58 gemcitabine cisplatin 58 Tranexamic acid 58 MDS MPD 58 MENOPUR 58 P#Y# [002] 58 echocardiographic parameters 58 timolol 58 HBeAg positive patients 58 fasting plasma glucose 58 neutropaenia 58 Teriflunomide 58 chronic eosinophilic leukemia 58 formoterol fumarate 58 androgen suppression 58 Darusentan 58 TLK# 58 intracerebral 58 bupropion SR 58 prostanoid 58 antiretroviral naive 58 ANOVA 58 reteplase 58 neutropenic sepsis 58 Virologic 58 p = .# [002] 58 Hb A1C 58 HIF 1a 58 daunorubicin 58 ALT normalization 58 Alkaline Phosphatase 58 ß blockers 58 paclitaxel cisplatin 58 disease progression TTP 58 complete cytogenetic response 58 oxcarbazepine 58 amprenavir 58 NATRECOR R 58 hour bronchodilation 58 treprostinil 58 occluded catheters 58 CI #.#-#.# [001] 58 Triapine R 58 AMEVIVE 58 severe renal impairment 58 blood phenylalanine Phe 58 neutrophil count 58 eosinophil count 58 interleukin IL -6 58 interleukin IL -# 58 concomitant medications 58 baroreceptor 58 cardiac contractility 58 Kaplan Meier analysis 58 macroalbuminuria 58 liposomal doxorubicin 58 CONCERTA 58 = #.#-#.# 58 receiving INTRON 58 eptifibatide 58 candesartan cilexetil 58 viral titers 58 RECIST Response Evaluation Criteria 58 cetuximab Erbitux ® 58 oblimersen 58 methotrexate monotherapy 58 Alanine 58 generation antisense inhibitor 58 BROVANA 58 allogeneic HSCT 58 estimated glomerular filtration 58 abacavir Ziagen 58 titrated glipizide 58 alanine transaminase 58 endothelium dependent 58 Fluticasone 58 Durezol 58 platelet inhibitor 58 phenelzine 58 thalidomide dexamethasone 58 antimetabolite 58 COZAAR 58 peginterferon 58 debulking surgery 58 prostate carcinoma 58 Myelodysplastic Syndrome MDS 58 idraparinux 58 primary percutaneous coronary 58 fluorouracil 58 serum lactate 58 Nebulized 58 LV dysfunction 58 serum calcium 58 corticosteroid therapy 58 docetaxel prednisone 58 HER2 overexpression 58 Rating Scale MADRS 58 ® lenalidomide 58 chloride secretion 58 anti HBs 58 RISPERDAL ® 58 Noxafil 58 x ULN 58 FFNS 58 autologous SCT 58 postprandial glucose 58 anti androgen 58 glycoprotein IIb IIIa inhibitor 58 adjuvant cisplatin 58 Scale EDSS 58 inhibin 58 ara C 58 CYP #A# 58 preterm neonates 58 azacitidine 58 hemoglobin hematocrit 58 melphalan prednisone 58 Abrupt discontinuation 58 Forodesine HCl 58 #mg BID [001] 58 amoxicillin clavulanate 58 methacholine 58 plasma leptin 58 N telopeptide 58 HIV RNA 58 quetiapine XR 58 #.#ng/ml 58 elotuzumab 58 dose dexamethasone 58 dopamine partial agonist 58 gefitinib Iressa 58 novel VDA molecule 58 apolipoprotein B 58 Capesaris 58 catheter occlusion 58 pharmacokinetic PK profile 58 oxymorphone ER 58 Pharmacokinetic parameters 58 beclomethasone dipropionate 58 evaluable subjects 58 voriconazole 58 HMG CoA reductase inhibitors 58 octreotide LAR 58 hypophosphatemia 58 transthoracic 58 BoNTA 58 serum HCV RNA 58 biologic DMARD 58 A1c levels 58 TNFalpha 58 TMP SMX 58 receptor inhibitor 58 platelet inhibition 58 WOMAC pain 58 ug mL 58 liposomal amphotericin B 58 cisplatin gemcitabine 58 TNF inhibitor 58 hypocalcemia 58 CYP#A# substrate 58 hepatic fibrosis 58 HES CEL 58 quetiapine Seroquel 58 #mmHg [002] 58 MBq 58 epoetin alfa 58 bleomycin 58 6MWD 58 experienced virologic failure 58 glycated hemoglobin HbA1c 58 paclitaxel Taxol 58 FIRMAGON 58 Pemetrexed 58 intranasal formulation 58 indinavir 58 6MWT 58 glulisine 58 androgen ablation 58 nevirapine Viramune 58 Peg IFN 58 DOXIL 58 Fasting blood glucose 58 mesalamine granules 58 timepoint 58 nephrotoxic 58 corticosteroid dexamethasone 58 postoperative chemotherapy 58 visilizumab 58 Montgomery Asberg Depression 58 INVEGA ® 58 GAMMAGARD 58 PEGPH# 58 DCCR 58 antiarrhythmic drugs 58 leucopenia 58 glucuronide 58 N acetylcysteine 58 SGRQ 58 GnRH agonists 58 test OGTT 58 L dopa 58 ICD shocks 58 peginterferon alfa 2b 58 PKC inhibitor 58 Alzheimer Disease Assessment 58 ug ml 58 CK # administered 58 amphotericin B 58 thromboembolic events 58 hyperammonemia 58 sonographically guided 58 dose atorvastatin 58 immunostaining 58 COMBIVIR 58 cisplatin vinorelbine 58 transdermal fentanyl 58 Adalimumab 58 trandolapril 58 renoprotective 58 serum albumin 58 mU liter 58 parathyroidectomy 58 Acetate Rectal Suppositories 58 left ventricular systolic 58 intravesical 58 CC genotype 58 neutropenic patients 58 angiotensin converting enzyme inhibitors 58 antiplatelet medication 58 vitro cytotoxicity 58 oocytes retrieved 58 receiving highly emetogenic 58 imipenem 58 inducible nitric oxide synthase 58 unfractionated heparin 58 cinacalcet 58 CHOP chemotherapy 58 MS relapses 58 levodopa carbidopa 58 alfuzosin 58 Score DAS# 58 antiandrogens 58 AGHD 58 humanised monoclonal antibody 57 adrenal suppression 57 atheroma volume 57 symptom exacerbation